Targeting the adenosinergic axis in cancer immunotherapy: Insights into A2A and A2B receptors and novel clinical combination strategies
- 21 September 2025
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 77 (6) , 100092
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Ciencia e Innovación (PID2024-155240OB-I00)
- Ministerio de Ciencia e Innovación (PID2021-124010OB-100)
- Centro Singular de Investigación de Galicia (ED431G 2023/03)
- European Cooperation in Science and Technology (CA18133)
- European Regional Development Fund
- Agencia Estatal de Investigación
- Federación Española de Enfermedades Raras
- Government of Galicia Department of Education Science Universities and Professional Training (ED431B2020/43)
- Government of Galicia Department of Education Science Universities and Professional Training (ED431B2023/23)
This publication has 157 references indexed in Scilit:
- STAT3 Signaling Pathway in Health and DiseaseMedcomm, 2025
- A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancerCancer Immunology, Immunotherapy, 2024
- Functional expression of CD73 on human natural killer cellsCancer Immunology, Immunotherapy, 2022
- Adenosine-producing regulatory B cells in head and neck cancerCancer Immunology, Immunotherapy, 2020
- Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer modelsCancer Immunology, Immunotherapy, 2018
- Polarizing Macrophages In Vitro2018
- Role of adenosine signaling in the pathogenesis of breast cancerJournal of Cellular Physiology, 2017
- Adenosine can thwart antitumor immune responses elicited by radiotherapyStrahlentherapie und Onkologie, 2016
- Adenosine receptors and their ligandsNaunyn-Schmiedeberg's Archives of Pharmacology, 2000
- Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptorsNaunyn-Schmiedeberg's Archives of Pharmacology, 1999